文献速递肺外科

周围型≤2cm临床N0非小细胞肺癌隐匿性N1淋巴结转移发生率

Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2019-08-31

本研究基于CALGB 140503试验筛选日志,纳入58例周围型≤2cm临床N0非小细胞肺癌患者,均接受解剖性切除及纵隔肺门淋巴结清扫。结果显示8例(14%)存在隐匿性N1转移,多位于叶间或支气管周围站(11或12站),另2例(3%)有隐匿性N2转移,临床分期假阴性率16%。结论强调肺门淋巴结清扫对小肺癌准确分期至关重要。

要点

  • 周围型≤2cm临床N0 NSCLC中隐匿性N1转移率达14%(8/58)。
  • 隐匿性N1多位于叶间或支气管周围站(11或12站),共11或12枚淋巴结。
  • 临床分期总体假阴性率为16%,肺门淋巴结清扫不可或缺。

核心结论

  • 周围型≤2cm临床N0非小细胞肺癌患者中隐匿性N1淋巴结转移常见,多位于11-13站。
  • 肺门淋巴结清扫对于小临床N0非小细胞肺癌的准确分期至关重要。

研究设计与样本

  • 研究基于本机构Alliance/Cancer and Leukemia Group B 140503试验的预注册资格筛查日志。
  • 纳入58例周围型≤2cm、临床T1a-b N0 M0(AJCC第8版)且适合肺叶或亚肺叶切除的NSCLC患者。
  • 所有患者接受解剖性切除联合纵隔和肺门淋巴结清扫,并分析病理结局。

主要发现

  • 58例中51例行肺叶切除,7例行肺段切除。
  • CT平均肿瘤直径为1.5 cm,PET最大标准化摄取均值3.9,平均实性成分与肿瘤比值为0.77。
  • 8例(14%)发现N1站隐匿性淋巴结转移,其中多数位于叶间或支气管周围站(11或12站)。
  • 另2例(3%)发现隐匿性N2阳性淋巴结。
  • 临床分期总体假阴性率为16%。

临床怎么用

  • 对周围型≤2cm临床N0 NSCLC,应行肺门淋巴结清扫以确保准确分期。
  • 局限切除或非手术治疗决策前需考虑隐匿性N1转移风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been growing interest in limited resection and nonsurgical treatment for small lung cancers. We examined the pattern and rate of occult N1 nodal metastasis in patients with peripheral, small (≤2 cm), clinically node-negative non-small cell lung cancer (NSCLC). METHODS: Patients with peripheral small (≤2 cm) NSCLC with no evidence of locally advanced or metastatic disease (clinical T1a-b N0 M0, American Joint Committee on Cancer 8th Edition Cancer Staging Manual), who were deemed eligible for lobectomy or sublobar resection, were identified from preregistration eligibility screening logs for the Alliance/Cancer and Leukemia Group B 140503 trial at our institution. Pathologic outcomes were examined in all patients undergoing anatomic resection with mediastinal and hilar lymphadenectomy. RESULTS: Included were 58 patients treated between November 2014 and January 2017 who met the inclusion criteria: 51 underwent lobectomy, and 7 underwent segmentectomy. Mean tumor diameter on computed tomography was 1.5 cm, and mean positron emission tomography maximal standardized uptake value was 3.9. The mean consolidation-to-tumor ratio was 0.77. Occult nodal metastases in N1 stations were found in 8 of 58 patients (14%), and most of these nodes were found in interlobar or peribronchial stations (11 or 12). An additional 2 patients (3%) had occult positive N2 nodes. Overall, the false-negative rate for clinical staging was 16%. CONCLUSIONS: Occult nodal disease was frequently identified in peripheral N1 stations (11-13) in patients with small (≤2 cm) clinical N0 NSCLC. Hilar lymphadenectomy is essential for accurate staging in the management of patients with small clinical N0 NSCLC.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Robinson EM, Ilonen IK, Tan KS, et al. Prevalence of Occult Peribronchial N1 Nodal Metastasis in Peripheral Clinical N0 Small (≤2 cm) Non-Small Cell Lung Cancer. Ann Thorac Surg. 2019. PMID: 31479639. doi:10.1016/j.athoracsur.2019.07.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。